Skip Navigation

European Heart Journal 2000 21(13):1046-1051; doi:10.1053/euhj.1999.1950
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Camm, A.J.
Right arrow Articles by Fox, K.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camm, A.J.
Right arrow Articles by Fox, K.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?

A.J. Cammf1 and K.M. Fox

St Georges Hospital, London
Royal Brompton and Harefield Hospitals, London, U.K.

revised September 7, 1999; accepted September 8, 1999

f1 Correspondence: A. J. Camm, St George's Hospital, London SW17, U.K.

References

  1. Azar RR, Waters DD. The inflammatory aetiology of unstable angina. Am Heart J. 1996;132:1101–1106[CrossRef][ISI][Medline]
  2. Ridker PM. Inflammation, infection and cardiovascular risk: how good is the evidence? Circulation. 1998;97:1671–1674[Free Full Text]
  3. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. Exp Med. 1978;148:335–340
  4. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42:2467–2469
  5. Melnick JL, Petrie BL, Dreesman GR. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644–647[ISI][Medline]
  6. Sorlie PD, Adam E, Melnick SL. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol. 1994;42:33–37[ISI][Medline]
  7. Zhou YF, Leon MB, Waclawiw MA. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624–630[Abstract/Free Full Text]
  8. McDonald K, Rector TS, Braunlin EA. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol. 1989;64:359–362[CrossRef][ISI][Medline]
  9. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436[CrossRef][ISI][Medline]
  10. Johnson DE, Gao SZ, Schroeder JS. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplantation. 1989;8:349–359[ISI][Medline]
  11. Mendall MA, Goggin PM, Molineaux N. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437–439[Abstract/Free Full Text]
  12. Martin-de-Agrila C, Boixeda D, Canton R. High seroprevalence of Helicobacter pylori infection in coronary heart disease. Lancet. 1995;346:310[Medline]
  13. Patel P, Mendall MA, Carrington D. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311:711–714[Abstract/Free Full Text]
  14. Murrary LJ, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease and social class. Br Heart J. 1995;74:497–501[Abstract/Free Full Text]
  15. Whincup PH, Medall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart. 1996;75:568–572[Abstract/Free Full Text]
  16. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large prospective study. BMJ. 1997;315:1199–1201[Abstract/Free Full Text]
  17. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta analysis of 18 studies. BMJ. 1998;316:1130–1132[Abstract/Free Full Text]
  18. Blasi F, Denti F, Erba M. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766–2769[Abstract]
  19. Pasceri V, Cammarota G, Patti G. Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation. 1998;97:1675–1679[Abstract/Free Full Text]
  20. Mattila KJ, Nieminen MS, Valtonen VV. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779–782[ISI][Medline]
  21. Jousilahti P, Vartianinen E, Tacomilekhot T. Symptoms of chronic bronchitis and risk of coronary disease. Lancet. 1996;348:567–572[CrossRef][ISI][Medline]
  22. Saikku P. The epidemiology and significance of Chlamydia pneumonia. J Infect. 1992;39:88–90[CrossRef]
  23. Saikku P, Mattila K, Nieminen MS. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986[ISI][Medline]
  24. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease: coincidence, association or causation? Br Med J. 1997;314:1778–1779[Free Full Text]
  25. Kuo CC, Shor A, Campbell LA. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841–849[ISI][Medline]
  26. Juvonen J, Laurila A, Juvonen T. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1991;29:1054–1059
  27. Moazed TC, Kuo CC, Patton DL. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Path. 1996;148:667–678[Abstract]
  28. Yang Z, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumonia following intranasal innoculation in mice. J Inf Dis. 1995;171:736–738[ISI][Medline]
  29. Jackson LA, Campbell LA, Schmidt RA. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Am J Path. 1997;150:1785–1790[Abstract]
  30. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Intern Med. 1996;125:979–982[Abstract/Free Full Text]
  31. Campbel LA, O'Brien ER, Capuccio AL. Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Inf Dis. 1995;172:585–588[ISI][Medline]
  32. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998;31:827–832[Abstract/Free Full Text]
  33. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immunol. 1996;64:1614–1620[Abstract]
  34. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995;73:10–13[Abstract/Free Full Text]
  35. Dahlen GH, Boman J, Birgander LS, Lindholm B. Lipoprotein(a), IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis. 1995;114:165–174[CrossRef][ISI][Medline]
  36. Holland MJ, Bailey RL, Ward ME, Morrison R, Whittle HC, Mabey DC. Cell mediated immune responses to Chlamydia trachomatis in scarring trachoma. Proc Eur Soc Chlam Res. 1992;2:134
  37. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:2910–2913[Abstract/Free Full Text]
  38. Cook PJ, Lip GH, Zafris J, Honeybourne D, Wise R, Beevers DG. Is Chlamydia pneumoniae infection associated with hypertension? (Abstr). J Hypertens. 1995;13:1495–1496[CrossRef]
  39. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae -coronary artery disease association. Arteriscler Thromb. 1992;12:945–947
  40. Fong IW, Chiu B, Viira E. Rabbit models for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:48–52[Abstract]
  41. Laitinen K, Laurila A, Pyhala L. Chlamydia pneumoniae induces inflammatory changes in the aortas of rabbit. Infect Immun. 1997;65:4832–4834[Abstract]
  42. Muhlestein JB, Anderson JL, Hammond EH. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:633–636[Abstract/Free Full Text]
  43. Liuzzo G, Biasucci LM, Gallimore R, Grillor RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417–424[Abstract/Free Full Text]
  44. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys M. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462–466[CrossRef][ISI][Medline]
  45. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404–407[Abstract/Free Full Text]
  46. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997;350:404–407[CrossRef][ISI][Medline]
  47. Anderson JL, Muhlestein JB, Carlquist J. Randomised secondary prevention trial of azithromycin with coronary artery disease and serological evidence for chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study. Circulation. 1999;99:1540–1547[Abstract/Free Full Text]
  48. Torgano G, Cosentini R, Mandelli C. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decrease fibrinogen plasma levels in patients with ischaemic heart disease. Circulation. 1999;99:1555–1559[Abstract/Free Full Text]
  49. Martin D, Bursill J, qui MR, Breit SN, Campbell T. Alternative hypothesis for efficacy of macrolides in acute coronary syndromes. Lancet. 1998;351:1858–1859[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
L. Robman, O. Mahdi, C. McCarty, P. Dimitrov, G. Tikellis, J. McNeil, G. Byrne, H. Taylor, and R. Guymer
Exposure to Chlamydia pneumoniae Infection and Progression of Age-related Macular Degeneration
Am. J. Epidemiol., June 1, 2005; 161(11): 1013 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
J. Boman and M. R. Hammerschlag
Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies
Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20.
[Abstract] [Full Text]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Camm, A.J.
Right arrow Articles by Fox, K.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Camm, A.J.
Right arrow Articles by Fox, K.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?